ABAX 53.84 Abaxis Inc $ABAX Hit a 52 week high of 54.71 Closing the day 11/06/14 at 53.84 -0.61 -1.12% With a day low of 53.57 and a total volume of 162,599.
ABAX Recent Posts: http://investorshangout.com/Abaxis-ABAX-53195/
ABAX Abaxis Inc Recent Headline News
Several Sectors Emerge As Leaders Of New Market Uptrend
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
Every new market uptrend brings new leadership, and this time technology, medical and business service stocks are emerging as market leaders. You can expect sector rotation -- the rise of new leaders as others fall out of favor -- when the market...
VDSI: 26.49 (+0.57), CTAS: 71.09 (+0.69), ABAX: 53.84 (-0.61), CPHD: 51.40 (-1.04), QLYS: 34.82 (+0.63), GK: 64.63 (+1.60), MANH: 40.56 (+0.68), TNET: 29.26 (-0.24), PAYC: 21.59 (+0.44)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 197.40 (+1.08), ABAX: 53.84 (-0.61), ABBV: 62.71 (+0.17), HSP: 56.64 (+3.54)
Abaxis (ABAX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:04AM CST
Abaxis (ABAX) Shares March Higher, Can It Continue?
ABAX: 53.84 (-0.61)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), COV: 92.60 (-0.72)
Insider Trading Alert - GNTX, ABAX And MFRM Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include GNTX, ABAX and MFRM
ABAX: 53.84 (-0.61), GNTX: 33.83 (+0.32), MFRM: 63.94 (+0.65)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04), SPHS: 3.01 (-0.07)
Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04), RMTI: 9.33 (+0.15)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.56 (-0.39), LMT: 189.88 (+0.15), MDT: 68.74 (+0.04), QDEL: 28.67 (+0.38), XOM: 96.26 (+1.19), CLF: 10.54 (-0.61), BA: 124.58 (+0.36), NUVA: 41.93 (+0.18), ANR: 2.52 (+0.09), BSX: 13.36 (+0.03), VLO: 50.24 (+0.60), BTU: 10.84 (+0.06), ABAX: 53.84 (-0.61), IMO: 46.89 (+0.34), ACI: 2.42 (+0.07)
Abaxis, Inc. to Present at the Stephens 2014 Fall Investment Conference
PR Newswire - Wed Nov 05, 7:00AM CST
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood instrumentation and consumables to the medical, research and veterinary markets, announced today that Don Wood, Chief Operating Officer, will present at the Stephens 2014 Fall Investment Conference on Tuesday, November 11, 2014 at 3:00 p.m. ET. The conference will be held at the New York Palace Hotel in New York City.
ABAX: 53.84 (-0.61)
CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.36 (+0.03), ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), CVS: 88.43 (+0.93)
Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.36 (+0.03), ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), HAE: 37.09 (+0.67)
Mead Johnson Tumbles as Danone Goes for Yashili in China - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:20AM CST
Pediatric nutrition products provider Mead Johnson Nutrition Company's (MJN) shares dropped 4.1% to close at $99.31 on Friday.
BSX: 13.36 (+0.03), MJN: 98.84 (+0.05), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61)
Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 72.05 (+0.20), CSII: 29.87 (-0.01), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04)
Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04), ATRC: 16.85 (+0.18)
Merge Healthcare Q3 Revenues Top Estimates, Earnings Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:10PM CDT
Merge Healthcare Incorporated (MRGE) reported third-quarter 2014 adjusted net income per share of 4 cents.
BSX: 13.36 (+0.03), ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), MRGE: 3.03 (+0.03)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.74 (+1.62), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), OMI: 34.22 (+0.52)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.74 (+1.62), MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61)
Walgreens Banks on Alliance Boots Deal, Headwinds Persist - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:35PM CDT
On Oct 27, we issued an updated research report on Walgreen Co. (WAG).
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), ALR: 40.07 (-0.13), WAG: 66.65 (+0.99)
Buy These 5 Breakout Health Care Stocks for Healthy Gains
at The Street - Tue Oct 28, 9:30AM CDT
Health care stocks have the highest relative strength of any sector, an indication that they are outperforming the broad market through rallies and corrections alike.
PCYC: 137.12 (+6.09), CBST: 70.91 (+0.16), ABAX: 53.84 (-0.61), INCY: 68.40 (+0.68), HUM: 139.87 (+0.93)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.74 (+1.62), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), BAX: 71.60 (+0.70)
ABAX Recent Posts: http://investorshangout.com/Abaxis-ABAX-53195/
ABAX Abaxis Inc Recent Headline News
Several Sectors Emerge As Leaders Of New Market Uptrend
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
Every new market uptrend brings new leadership, and this time technology, medical and business service stocks are emerging as market leaders. You can expect sector rotation -- the rise of new leaders as others fall out of favor -- when the market...
VDSI: 26.49 (+0.57), CTAS: 71.09 (+0.69), ABAX: 53.84 (-0.61), CPHD: 51.40 (-1.04), QLYS: 34.82 (+0.63), GK: 64.63 (+1.60), MANH: 40.56 (+0.68), TNET: 29.26 (-0.24), PAYC: 21.59 (+0.44)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 197.40 (+1.08), ABAX: 53.84 (-0.61), ABBV: 62.71 (+0.17), HSP: 56.64 (+3.54)
Abaxis (ABAX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:04AM CST
Abaxis (ABAX) Shares March Higher, Can It Continue?
ABAX: 53.84 (-0.61)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), COV: 92.60 (-0.72)
Insider Trading Alert - GNTX, ABAX And MFRM Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include GNTX, ABAX and MFRM
ABAX: 53.84 (-0.61), GNTX: 33.83 (+0.32), MFRM: 63.94 (+0.65)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04), SPHS: 3.01 (-0.07)
Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04), RMTI: 9.33 (+0.15)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.56 (-0.39), LMT: 189.88 (+0.15), MDT: 68.74 (+0.04), QDEL: 28.67 (+0.38), XOM: 96.26 (+1.19), CLF: 10.54 (-0.61), BA: 124.58 (+0.36), NUVA: 41.93 (+0.18), ANR: 2.52 (+0.09), BSX: 13.36 (+0.03), VLO: 50.24 (+0.60), BTU: 10.84 (+0.06), ABAX: 53.84 (-0.61), IMO: 46.89 (+0.34), ACI: 2.42 (+0.07)
Abaxis, Inc. to Present at the Stephens 2014 Fall Investment Conference
PR Newswire - Wed Nov 05, 7:00AM CST
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood instrumentation and consumables to the medical, research and veterinary markets, announced today that Don Wood, Chief Operating Officer, will present at the Stephens 2014 Fall Investment Conference on Tuesday, November 11, 2014 at 3:00 p.m. ET. The conference will be held at the New York Palace Hotel in New York City.
ABAX: 53.84 (-0.61)
CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.36 (+0.03), ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), CVS: 88.43 (+0.93)
Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.36 (+0.03), ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), HAE: 37.09 (+0.67)
Mead Johnson Tumbles as Danone Goes for Yashili in China - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 10:20AM CST
Pediatric nutrition products provider Mead Johnson Nutrition Company's (MJN) shares dropped 4.1% to close at $99.31 on Friday.
BSX: 13.36 (+0.03), MJN: 98.84 (+0.05), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61)
Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 72.05 (+0.20), CSII: 29.87 (-0.01), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04)
Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), GWPH: 74.38 (+3.04), ATRC: 16.85 (+0.18)
Merge Healthcare Q3 Revenues Top Estimates, Earnings Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:10PM CDT
Merge Healthcare Incorporated (MRGE) reported third-quarter 2014 adjusted net income per share of 4 cents.
BSX: 13.36 (+0.03), ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), MRGE: 3.03 (+0.03)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.74 (+1.62), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), OMI: 34.22 (+0.52)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.74 (+1.62), MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61)
Walgreens Banks on Alliance Boots Deal, Headwinds Persist - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:35PM CDT
On Oct 27, we issued an updated research report on Walgreen Co. (WAG).
ICUI: 72.05 (+0.20), ABAX: 53.84 (-0.61), ALR: 40.07 (-0.13), WAG: 66.65 (+0.99)
Buy These 5 Breakout Health Care Stocks for Healthy Gains
at The Street - Tue Oct 28, 9:30AM CDT
Health care stocks have the highest relative strength of any sector, an indication that they are outperforming the broad market through rallies and corrections alike.
PCYC: 137.12 (+6.09), CBST: 70.91 (+0.16), ABAX: 53.84 (-0.61), INCY: 68.40 (+0.68), HUM: 139.87 (+0.93)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.74 (+1.62), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), BAX: 71.60 (+0.70)
